Literature DB >> 10952671

Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors.

A J McLean1, G Milligan.   

Abstract

Stable clones of HEK293 cells expressing either FLAG(TM) epitope-tagged, wild type human beta(1)- and beta(2)-adrenoceptors or C-terminally green fluorescent protein (GFP)-tagged forms of these receptors were established. The binding affinity of [(3)H]-dihydroalprenolol and other ligands was little affected by addition of GFP to the C-terminal of either receptor. Isoprenaline induced the internalisation of both beta(1)-adrenoceptor-GFP and beta(2)-adrenoceptor-GFP and following removal of the agonist both constructs were able to recycle to the cell surface. The extent of internalisation of beta(2)-adrenoceptor-GFP produced by isoprenaline was substantially greater than for beta(1)-adrenoceptor-GFP. C-terminal addition of GFP slowed markedly the rate of internalization of both the beta(1)-adrenoceptor and the beta(2)-adrenoceptor in response to isoprenaline. Sustained exposure to isoprenaline (24 h) produced substantially greater levels of downregulation of native beta(2)-adrenoceptor compared to beta(2)-adrenoceptor-GFP although both were equally effectively removed from the plasma membrane. Sustained exposure to isoprenaline resulted in a large fraction of beta(2)-adrenoceptor-GFP becoming trapped in internal vesicles/lysosomes but not degraded. Even after sustained exposure to isoprenaline a significant fraction of beta(1)-adrenoceptor-GFP remained at the cell surface. These results indicate that although GFP tagging of beta-adrenoceptors can provide qualitative visual patterns of agonist-induced receptor trafficking and regulation in HEK293 cells the quantitative details vary markedly from those obtained with the unmodified receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952671      PMCID: PMC1572266          DOI: 10.1038/sj.bjp.0703506

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Regulation of spontaneous activity of the delta-opioid receptor: studies of inverse agonism in intact cells.

Authors:  M Merkouris; I Mullaney; Z Georgoussi; G Milligan
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

2.  Internal trafficking and surface mobility of a functionally intact beta2-adrenergic receptor-green fluorescent protein conjugate.

Authors:  L S Barak; S S Ferguson; J Zhang; C Martenson; T Meyer; M G Caron
Journal:  Mol Pharmacol       Date:  1997-02       Impact factor: 4.436

3.  The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange.

Authors:  R A Hall; R T Premont; C W Chow; J T Blitzer; J A Pitcher; A Claing; R H Stoffel; L S Barak; S Shenolikar; E J Weinman; S Grinstein; R J Lefkowitz
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

4.  A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor.

Authors:  T T Cao; H W Deacon; D Reczek; A Bretscher; M von Zastrow
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

5.  Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A.

Authors:  N I Tarasova; R H Stauber; J K Choi; E A Hudson; G Czerwinski; J L Miller; G N Pavlakis; C J Michejda; S A Wank
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

6.  Visualization of agonist-induced sequestration and down-regulation of a green fluorescent protein-tagged beta2-adrenergic receptor.

Authors:  L Kallal; A W Gagnon; R B Penn; J L Benovic
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

7.  Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype.

Authors:  A Hirasawa; T Sugawara; T Awaji; K Tsumaya; H Ito; G Tsujimoto
Journal:  Mol Pharmacol       Date:  1997-11       Impact factor: 4.436

8.  Following cell fate in the living mouse embryo.

Authors:  M Zernicka-Goetz; J Pines; S McLean Hunter; J P Dixon; K R Siemering; J Haseloff; M J Evans
Journal:  Development       Date:  1997-03       Impact factor: 6.868

9.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

Authors:  L M Luttrell; S S Ferguson; Y Daaka; W E Miller; S Maudsley; G J Della Rocca; F Lin; H Kawakatsu; K Owada; D K Luttrell; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

Review 10.  Heptahelical receptor signaling: beyond the G protein paradigm.

Authors:  R A Hall; R T Premont; R J Lefkowitz
Journal:  J Cell Biol       Date:  1999-05-31       Impact factor: 10.539

View more
  29 in total

1.  Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.

Authors:  D Ramsay; N Bevan; S Rees; G Milligan
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5.

Authors:  Xiang Li; George S Baillie; Miles D Houslay
Journal:  J Biol Chem       Date:  2009-04-16       Impact factor: 5.157

Review 3.  Membrane organization and dynamics of the G-protein-coupled serotonin1A receptor monitored using fluorescence-based approaches.

Authors:  Thomas J Pucadyil; Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  J Fluoresc       Date:  2005-09       Impact factor: 2.217

4.  Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.

Authors:  Graeme B Bolger; George S Baillie; Xiang Li; Martin J Lynch; Pawel Herzyk; Ahmed Mohamed; Lisa High Mitchell; Angela McCahill; Christian Hundsrucker; Enno Klussmann; David R Adams; Miles D Houslay
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

Review 5.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

6.  Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor.

Authors:  Jillian G Baker; Ian P Hall; Stephen J Hill
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

7.  The metabotropic glutamate receptor 4 is internalized and desensitized upon protein kinase C activation.

Authors:  Jesper Mosolff Mathiesen; M Teresa Ramirez
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

Review 8.  New technologies: bioluminescence resonance energy transfer (BRET) for the detection of real time interactions involving G-protein coupled receptors.

Authors:  Kevin Donald George Pfleger; Karin Ann Eidne
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

9.  Rapid recycling of beta-adrenergic receptors is dependent on the actin cytoskeleton and myosin Vb.

Authors:  Ellen E Millman; Haibin Zhang; Haixia Zhang; Veronica Godines; Andrew J Bean; Brian J Knoll; Robert H Moore
Journal:  Traffic       Date:  2008-08-09       Impact factor: 6.215

10.  Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays.

Authors:  George S Baillie; David R Adams; Narinder Bhari; Thomas M Houslay; Suryakiran Vadrevu; Dong Meng; Xiang Li; Allan Dunlop; Graeme Milligan; Graeme B Bolger; Enno Klussmann; Miles D Houslay
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.